
    
      The purposes of this trial are:

        -  To study the efficacy of alendronate in HIV-associated osteoporosis

        -  To measure the prevalence of osteoporosis in HIV patients and to detect risk factors in
           a large cohort of HIV patients from the screening phase
    
  